Print version
(pdf format 40 pages, 424KB)

NIH Publication No. 02-3929
Revised April 2002, Reprinted September 2002 |
|
|
This booklet is designed to help mental
health patients and their families understand how and why medications
can be used as part of the treatment of mental health problems.
It is important for you to be well
informed about medications you may need. You should know what
medications you take and the dosage, and learn everything you can about
them. Many medications now come with patient package inserts, describing
the medication, how it should be taken, and side effects to look for.
When you go to a new doctor, always take with you a list of all of the
prescribed medications (including dosage), over-the-counter medications,
and vitamin, mineral, and herbal supplements you take. The list should
include herbal teas and supplements such as St. John's wort, echinacea,
ginkgo, ephedra, and ginseng. Almost any substance that can change
behavior can cause harm if used in the wrong amount or frequency of
dosing, or in a bad combination. Drugs differ in the speed, duration of
action, and in their margin for error.
|
If you are taking more than one medication, and at different times
of the day, it is essential that you take the correct dosage of each
medication. An easy way to make sure you do this is to use a 7-day
pillbox, available in any pharmacy, and to fill the box with the
proper medication at the beginning of each week. Many pharmacies
also have pillboxes with sections for medications that must be taken
more than once a day. |
This booklet is intended to inform you,
but it is not a "do-it-yourself" manual. Leave it to the doctor, working
closely with you, to diagnose mental illness, interpret signs and
symptoms of the illness, prescribe and manage medication, and explain
any side effects. This will help you ensure that you use medication most
effectively and with minimum risk of side effects or complications.
Anyone can develop a mental
illness-you, a family member, a friend, or a neighbor. Some disorders
are mild; others are serious and long-lasting. These conditions can be
diagnosed and treated. Most people can live better lives after
treatment. And psychotherapeutic medications are an increasingly
important element in the successful treatment of mental illness.
Medications for mental illnesses were
first introduced in the early 1950s with the antipsychotic
chlorpromazine. Other medications have followed. These medications have
changed the lives of people with these disorders for the better.
Psychotherapeutic medications also may
make other kinds of treatment more effective. Someone who is too
depressed to talk, for instance, may have difficulty communicating
during psychotherapy or counseling, but the right medication may improve
symptoms so the person can respond. For many patients, a combination of
psychotherapy and medication can be an effective method of treatment.
Another benefit of these medications is
an increased understanding of the causes of mental illness. Scientists
have learned much more about the workings of the brain as a result of
their investigations into how psychotherapeutic medications relieve the
symptoms of disorders such as psychosis, depression, anxiety,
obsessive-compulsive disorder, and panic disorder.
Just as aspirin can reduce a fever
without curing the infection that causes it, psychotherapeutic
medications act by controlling symptoms. Psychotherapeutic medications
do not cure mental illness, but in many cases, they can help a person
function despite some continuing mental pain and difficulty coping with
problems. For example, drugs like chlorpromazine can turn off the
"voices" heard by some people with psychosis and help them to see
reality more clearly. And antidepressants can lift the dark, heavy moods
of depression. The degree of response--ranging from a little relief of
symptoms to complete relief--depends on a variety of factors related to
the individual and the disorder being treated.
How long someone must take a
psychotherapeutic medication depends on the individual and the disorder.
Many depressed and anxious people may need medication for a single
period--perhaps for several months--and then never need it again. People
with conditions such as schizophrenia or bipolar disorder (also known as
manic-depressive illness), or those whose depression or anxiety is
chronic or recurrent, may have to take medication indefinitely.
Like any medication, psychotherapeutic
medications do not produce the same effect in everyone. Some people may
respond better to one medication than another. Some may need larger
dosages than others do. Some have side effects, and others do not. Age,
sex, body size, body chemistry, physical illnesses and their treatments,
diet, and habits such as smoking are some of the factors that can
influence a medication's effect.
You and your family can help your
doctor find the right medications for you. The doctor needs to know your
medical history, other medications being taken, and life plans such as
hoping to have a baby. After taking the medication for a short time, you
should tell the doctor about favorable results as well as side effects.
The Food and Drug Administration (FDA) and professional organizations
recommend that the patient or a family member ask the following
questions when a medication is prescribed:
- What is the name of the medication,
and what is it supposed to do?
- How and when do I take it, and when
do I stop taking it?
- What foods, drinks, or other
medications should I avoid while taking the prescribed medication?
- Should it be taken with food or on
an empty stomach?
- Is it safe to drink alcohol while on
this medication?
- What are the side effects, and what
should I do if they occur?
- Is a Patient Package Insert for the
medication available?
This booklet describes medications by
their generic (chemical) names and in italics by their trade names
(brand names used by pharmaceutical companies). They are divided into
four large categories--antipsychotic, antimanic, antidepressant, and
antianxiety medications. Medications that specifically affect children,
the elderly, and women during the reproductive years are discussed in a
separate section of the booklet.
Lists at the end of the booklet give
the generic name and the trade name of the most commonly prescribed
medications and note the section of the booklet that contains
information about each type. A separate chart shows the trade and
generic names of medications commonly prescribed for children and
adolescents.
Treatment evaluation studies have
established the effectiveness of the medications described here, but
much remains to be learned about them. The National Institute of Mental
Health, other Federal agencies, and private research groups are
sponsoring studies of these medications. Scientists are hoping to
improve their understanding of how and why these medications work, how
to control or eliminate unwanted side effects, and how to make the
medications more effective.
A person who is psychotic is out of
touch with reality. People with psychosis may hear "voices" or have
strange and illogical ideas (for example, thinking that others can hear
their thoughts, or are trying to harm them, or that they are the
President of the United States or some other famous person). They may
get excited or angry for no apparent reason, or spend a lot of time by
themselves, or in bed, sleeping during the day and staying awake at
night. The person may neglect appearance, not bathing or changing
clothes, and may be hard to talk to--barely talking or saying things
that make no sense. They often are initially unaware that their
condition is an illness.
These kinds of behaviors are symptoms
of a psychotic illness such as schizophrenia. Antipsychotic medications
act against these symptoms. These medications cannot "cure" the illness,
but they can take away many of the symptoms or make them milder. In some
cases, they can shorten the course of an episode of the illness as well.
There are a number of antipsychotic (neuroleptic)
medications available. These medications affect neurotransmitters that
allow communication between nerve cells. One such neurotransmitter,
dopamine, is thought to be relevant to schizophrenia symptoms. All these
medications have been shown to be effective for schizophrenia. The main
differences are in the potency--that is, the dosage (amount) prescribed
to produce therapeutic effects-and the side effects. Some people might
think that the higher the dose of medication prescribed, the more
serious the illness; but this is not always true.
The first antipsychotic medications
were introduced in the 1950s. Antipsychotic medications have helped many
patients with psychosis lead a more normal and fulfilling life by
alleviating such symptoms as hallucinations, both visual and auditory,
and paranoid thoughts. However, the early antipsychotic medications
often have unpleasant side effects, such as muscle stiffness, tremor,
and abnormal movements, leading researchers to continue their search for
better drugs.
The 1990s saw the development of
several new drugs for schizophrenia, called "atypical antipsychotics."
Because they have fewer side effects than the older drugs, today they
are often used as a first-line treatment. The first atypical
antipsychotic, clozapine (Clozaril), was introduced in the United
States in 1990. In clinical trials, this medication was found to be more
effective than conventional or "typical" antipsychotic medications in
individuals with treatment-resistant schizophrenia (schizophrenia that
has not responded to other drugs), and the risk of tardive dyskinesia (a
movement disorder) was lower. However, because of the potential side
effect of a serious blood disorder--agranulocytosis (loss of the white
blood cells that fight infection)-patients who are on clozapine must
have a blood test every 1 or 2 weeks. The inconvenience and cost of
blood tests and the medication itself have made maintenance on clozapine
difficult for many people. Clozapine, however, continues to be the drug
of choice for treatment-resistant schizophrenia patients.
Several other atypical antipsychotics
have been developed since clozapine was introduced. The first was
risperidone (Risperdal), followed by olanzapine (Zyprexa),
quetiapine (Seroquel), and ziprasidone (Geodon). Each has
a unique side effect profile, but in general, these medications are
better tolerated than the earlier drugs.
All these medications have their place
in the treatment of schizophrenia, and doctors will choose among them.
They will consider the person's symptoms, age, weight, and personal and
family medication history.
Dosages and side effects.
Some drugs are very potent and the doctor may prescribe a low dose.
Other drugs are not as potent and a higher dose may be prescribed.
Unlike some prescription drugs, which
must be taken several times during the day, some antipsychotic
medications can be taken just once a day. In order to reduce daytime
side effects such as sleepiness, some medications can be taken at
bedtime. Some antipsychotic medications are available in "depot" forms
that can be injected once or twice a month.
Most side effects of antipsychotic
medications are mild. Many common ones lessen or disappear after the
first few weeks of treatment. These include drowsiness, rapid heartbeat,
and dizziness when changing position.
Some people gain weight while taking
medications and need to pay extra attention to diet and exercise to
control their weight. Other side effects may include a decrease in
sexual ability or interest, problems with menstrual periods, sunburn, or
skin rashes. If a side effect occurs, the doctor should be told. He or
she may prescribe a different medication, change the dosage or schedule,
or prescribe an additional medication to control the side effects.
Just as people vary in their responses
to antipsychotic medications, they also vary in how quickly they
improve. Some symptoms may diminish in days; others take weeks or
months. Many people see substantial improvement by the sixth week of
treatment. If there is no improvement, the doctor may try a different
type of medication. The doctor cannot tell beforehand which medication
will work for a person. Sometimes a person must try several medications
before finding one that works.
If a person is feeling better or even
completely well, the medication should not be stopped without talking to
the doctor. It may be necessary to stay on the medication to continue
feeling well. If, after consultation with the doctor, the decision is
made to discontinue the medication, it is important to continue to see
the doctor while tapering off medication. Many people with bipolar
disorder, for instance, require antipsychotic medication only for a
limited time during a manic episode until mood-stabilizing medication
takes effect. On the other hand, some people may need to take
antipsychotic medication for an extended period of time. These people
usually have chronic (long-term, continuous) schizophrenic disorders, or
have a history of repeated schizophrenic episodes, and are likely to
become ill again. Also, in some cases a person who has experienced one
or two severe episodes may need medication indefinitely. In these cases,
medication may be continued in as low a dosage as possible to maintain
control of symptoms. This approach, called maintenance treatment,
prevents relapse in many people and removes or reduces symptoms for
others.
Multiple medications.
Antipsychotic medications can produce unwanted effects when taken with
other medications. Therefore, the doctor should be told about all
medicines being taken, including over-the-counter medications and
vitamin, mineral, and herbal supplements, and the extent of alcohol use.
Some antipsychotic medications interfere with antihypertensive
medications (taken for high blood pressure), anticonvulsants (taken for
epilepsy), and medications used for Parkinson's disease. Other
antipsychotics add to the effect of alcohol and other central nervous
system depressants such as antihistamines, antidepressants,
barbiturates, some sleeping and pain medications, and narcotics.
Other effects.
Long-term treatment of schizophrenia with one of the older, or
"conventional," antipsychotics may cause a person to develop tardive
dyskinesia (TD). Tardive dyskinesia is a condition characterized by
involuntary movements, most often around the mouth. It may range from
mild to severe. In some people, it cannot be reversed, while others
recover partially or completely. Tardive dyskinesia is sometimes seen in
people with schizophrenia who have never been treated with an
antipsychotic medication; this is called "spontaneous dyskinesia."1
However, it is most often seen after long-term treatment with older
antipsychotic medications. The risk has been reduced with the newer
"atypical" medications. There is a higher incidence in women, and the
risk rises with age. The possible risks of long-term treatment with an
antipsychotic medication must be weighed against the benefits in each
case. The risk for TD is 5 percent per year with older medications; it
is less with the newer medications.
Bipolar disorder is characterized by
cycling mood changes: severe highs (mania) and lows (depression).
Episodes may be predominantly manic or depressive, with normal mood
between episodes. Mood swings may follow each other very closely, within
days (rapid cycling), or may be separated by months to years. The
"highs" and "lows" may vary in intensity and severity and can co-exist
in "mixed" episodes.
When people are in a manic "high," they
may be overactive, overly talkative, have a great deal of energy, and
have much less need for sleep than normal. They may switch quickly from
one topic to another, as if they cannot get their thoughts out fast
enough. Their attention span is often short, and they can be easily
distracted. Sometimes people who are "high" are irritable or angry and
have false or inflated ideas about their position or importance in the
world. They may be very elated, and full of grand schemes that might
range from business deals to romantic sprees. Often, they show poor
judgment in these ventures. Mania, untreated, may worsen to a psychotic
state.
In a depressive cycle the person may
have a "low" mood with difficulty concentrating; lack of energy, with
slowed thinking and movements; changes in eating and sleeping patterns
(usually increases of both in bipolar depression); feelings of
hopelessness, helplessness, sadness, worthlessness, guilt; and,
sometimes, thoughts of suicide.
Lithium. The medication
used most often to treat bipolar disorder is lithium. Lithium evens out
mood swings in both directions--from mania to depression, and depression
to mania--so it is used not just for manic attacks or flare-ups of the
illness but also as an ongoing maintenance treatment for bipolar
disorder.
Although lithium will reduce severe
manic symptoms in about 5 to 14 days, it may be weeks to several months
before the condition is fully controlled. Antipsychotic medications are
sometimes used in the first several days of treatment to control manic
symptoms until the lithium begins to take effect. Antidepressants may
also be added to lithium during the depressive phase of bipolar
disorder. If given in the absence of lithium or another mood stabilizer,
antidepressants may provoke a switch into mania in people with bipolar
disorder.
A person may have one episode of
bipolar disorder and never have another, or be free of illness for
several years. But for those who have more than one manic episode,
doctors usually give serious consideration to maintenance (continuing)
treatment with lithium.
Some people respond well to maintenance
treatment and have no further episodes. Others may have moderate mood
swings that lessen as treatment continues, or have less frequent or less
severe episodes. Unfortunately, some people with bipolar disorder may
not be helped at all by lithium. Response to treatment with lithium
varies, and it cannot be determined beforehand who will or will not
respond to treatment.
Regular blood tests are an important
part of treatment with lithium. If too little is taken, lithium will not
be effective. If too much is taken, a variety of side effects may occur.
The range between an effective dose and a toxic one is small. Blood
lithium levels are checked at the beginning of treatment to determine
the best lithium dosage. Once a person is stable and on a maintenance
dosage, the lithium level should be checked every few months. How much
lithium people need to take may vary over time, depending on how ill
they are, their body chemistry, and their physical condition.
Side effects of lithium.
When people first take lithium, they may experience side effects such as
drowsiness, weakness, nausea, fatigue, hand tremor, or increased thirst
and urination. Some may disappear or decrease quickly, although hand
tremor may persist. Weight gain may also occur. Dieting will help, but
crash diets should be avoided because they may raise or lower the
lithium level. Drinking low-calorie or no-calorie beverages, especially
water, will help keep weight down. Kidney changes--increased urination
and, in children, enuresis (bed wetting)--may develop during treatment.
These changes are generally manageable and are reduced by lowering the
dosage. Because lithium may cause the thyroid gland to become
underactive (hypothyroidism) or sometimes enlarged (goiter), thyroid
function monitoring is a part of the therapy. To restore normal thyroid
function, thyroid hormone may be given along with lithium.
Because of possible complications,
doctors either may not recommend lithium or may prescribe it with
caution when a person has thyroid, kidney, or heart disorders, epilepsy,
or brain damage. Women of childbearing age should be aware that lithium
increases the risk of congenital malformations in babies. Special
caution should be taken during the first 3 months of pregnancy.
Anything that lowers the level of
sodium in the body--reduced intake of table salt, a switch to a low-salt
diet, heavy sweating from an unusual amount of exercise or a very hot
climate, fever, vomiting, or diarrhea--may cause a lithium buildup and
lead to toxicity. It is important to be aware of conditions that lower
sodium or cause dehydration and to tell the doctor if any of these
conditions are present so the dose can be changed.
Lithium, when combined with certain
other medications, can have unwanted effects. Some diuretics--substances
that remove water from the body--increase the level of lithium and can
cause toxicity. Other diuretics, like coffee and tea, can lower the
level of lithium. Signs of lithium toxicity may include nausea,
vomiting, drowsiness, mental dullness, slurred speech, blurred vision,
confusion, dizziness, muscle twitching, irregular heartbeat, and,
ultimately, seizures. A lithium overdose can be life-threatening.
People who are taking lithium should tell every doctor who is treating
them, including dentists, about all medications they are taking.
With regular monitoring, lithium is a
safe and effective drug that enables many people, who otherwise would
suffer from incapacitating mood swings, to lead normal lives.
Anticonvulsants. Some
people with symptoms of mania who do not benefit from or would prefer to
avoid lithium have been found to respond to anticonvulsant medications
commonly prescribed to treat seizures.
The anticonvulsant valproic acid (Depakote,
divalproex sodium) is the main alternative therapy for bipolar
disorder. It is as effective in non-rapid-cycling bipolar disorder as
lithium and appears to be superior to lithium in rapid-cycling bipolar
disorder.2 Although valproic acid can
cause gastrointestinal side effects, the incidence is low. Other adverse
effects occasionally reported are headache, double vision, dizziness,
anxiety, or confusion. Because in some cases valproic acid has caused
liver dysfunction, liver function tests should be performed before
therapy and at frequent intervals thereafter, particularly during the
first 6 months of therapy.
|
Studies conducted in Finland in patients with
epilepsy have shown that valproic acid may increase testosterone
levels in teenage girls and produce polycystic ovary syndrome (POS)in
women who began taking the medication before age 20.3,4
POS can cause obesity, hirsutism (body hair), and amenorrhea.
Therefore, young female patients should be monitored carefully by a
doctor. |
Other anticonvulsants used for bipolar
disorder include carbamazepine (Tegretol), lamotrigine (Lamictal),
gabapentin (Neurontin), and topiramate (Topamax). The
evidence for anticonvulsant effectiveness is stronger for acute mania
than for long-term maintenance of bipolar disorder. Some studies suggest
particular efficacy of lamotrigine in bipolar depression. At present,
the lack of formal FDA approval of anticonvulsants other than valproic
acid for bipolar disorder may limit insurance coverage for these
medications.
Most people who have bipolar disorder
take more than one medication. Along with the mood stabilizer--lithium
and/or an anticonvulsant--they may take a medication for accompanying
agitation, anxiety, insomnia, or depression. It is important to continue
taking the mood stabilizer when taking an antidepressant because
research has shown that treatment with an antidepressant alone increases
the risk that the patient will switch to mania or hypomania, or develop
rapid cycling.5 Sometimes, when a bipolar
patient is not responsive to other medications, an atypical
antipsychotic medication is prescribed. Finding the best possible
medication, or combination of medications, is of utmost importance to
the patient and requires close monitoring by a doctor and strict
adherence to the recommended treatment regimen.
Major depression, the kind of
depression that will most likely benefit from treatment with
medications, is more than just "the blues." It is a condition that lasts
2 weeks or more, and interferes with a person's ability to carry on
daily tasks and enjoy activities that previously brought pleasure.
Depression is associated with abnormal functioning of the brain. An
interaction between genetic tendency and life history appears to
determine a person's chance of becoming depressed. Episodes of
depression may be triggered by stress, difficult life events, side
effects of medications, or medication/substance withdrawal, or even
viral infections that can affect the brain.
Depressed people will seem sad, or
"down," or may be unable to enjoy their normal activities. They may have
no appetite and lose weight (although some people eat more and gain
weight when depressed). They may sleep too much or too little, have
difficulty going to sleep, sleep restlessly, or awaken very early in the
morning. They may speak of feeling guilty, worthless, or hopeless; they
may lack energy or be jumpy and agitated. They may think about killing
themselves and may even make a suicide attempt. Some depressed people
have delusions (false, fixed ideas) about poverty, sickness, or
sinfulness that are related to their depression. Often feelings of
depression are worse at a particular time of day, for instance, every
morning or every evening.
Not everyone who is depressed has all
these symptoms, but everyone who is depressed has at least some of them,
co-existing, on most days. Depression can range in intensity from mild
to severe. Depression can co-occur with other medical disorders such as
cancer, heart disease, stroke, Parkinson's disease, Alzheimer's disease,
and diabetes. In such cases, the depression is often overlooked and is
not treated. If the depression is recognized and treated, a person's
quality of life can be greatly improved.
Antidepressants are used most often for
serious depressions, but they can also be helpful for some milder
depressions. Antidepressants are not "uppers" or stimulants, but rather
take away or reduce the symptoms of depression and help depressed people
feel the way they did before they became depressed.
The doctor chooses an antidepressant
based on the individual's symptoms. Some people notice improvement in
the first couple of weeks; but usually the medication must be taken
regularly for at least 6 weeks and, in some cases, as many as 8 weeks
before the full therapeutic effect occurs. If there is little or no
change in symptoms after 6 or 8 weeks, the doctor may prescribe a
different medication or add a second medication such as lithium, to
augment the action of the original antidepressant. Because there is no
way of knowing beforehand which medication will be effective, the doctor
may have to prescribe first one and then another. To give a medication
time to be effective and to prevent a relapse of the depression once the
patient is responding to an antidepressant, the medication should be
continued for 6 to 12 months, or in some cases longer, carefully
following the doctor's instructions. When a patient and the doctor feel
that medication can be discontinued, withdrawal should be discussed as
to how best to taper off the medication gradually. Never discontinue
medication without talking to the doctor about it. For those who
have had several bouts of depression, long-term treatment with
medication is the most effective means of preventing more episodes.
Dosage of antidepressants varies,
depending on the type of drug and the person's body chemistry, age, and,
sometimes, body weight. Traditionally, antidepressant dosages are
started low and raised gradually over time until the desired effect is
reached without the appearance of troublesome side effects. Newer
antidepressants may be started at or near therapeutic doses.
Early antidepressants.
From the 1960s through the 1980s, tricyclic antidepressants
(named for their chemical structure) were the first line of treatment
for major depression. Most of these medications affected two chemical
neurotransmitters, norepinephrine and serotonin. Though the tricyclics
are as effective in treating depression as the newer antidepressants,
their side effects are usually more unpleasant; thus, today tricyclics
such as imipramine, amitriptyline, nortriptyline, and desipramine are
used as a second- or third-line treatment. Other antidepressants
introduced during this period were monoamine oxidase inhibitors (MAOIs).
MAOIs are effective for some people with major depression who do not
respond to other antidepressants. They are also effective for the
treatment of panic disorder and bipolar depression. MAOIs approved for
the treatment of depression are phenelzine (Nardil), tranylcypromine (Parnate),
and isocarboxazid (Marplan). Because substances in certain foods,
beverages, and medications can cause dangerous interactions when
combined with MAOIs, people on these agents must adhere to dietary
restrictions. This has deterred many clinicians and patients from using
these effective medications, which are in fact quite safe when used as
directed.
The past decade has seen the
introduction of many new antidepressants that work as well as the older
ones but have fewer side effects. Some of these medications primarily
affect one neurotransmitter, serotonin, and are called selective
serotonin reuptake inhibitors (SSRIs). These include fluoxetine (Prozac),
sertraline (Zoloft), fluvoxamine (Luvox), paroxetine (Paxil),
and citalopram (Celexa).
The late 1990s ushered in new
medications that, like the tricyclics, affect both norepinephrine and
serotonin but have fewer side effects. These new medications include
venlafaxine (Effexor) and nefazadone (Serzone).
|
Cases of life-threatening hepatic failure have been reported in
patients treated with nefazodone (Serzone). Patients should call the
doctor if the following symptoms of liver dysfunction occur -
yellowing of the skin or white of eyes, unusually dark urine, loss
of appetite that lasts for several days, nausea, or abdominal pain. |
Other newer medications chemically
unrelated to the other antidepressants are the sedating mirtazepine (Remeron)
and the more activating bupropion (Wellbutrin). Wellbutrin has
not been associated with weight gain or sexual dysfunction but is not
used for people with, or at risk for, a seizure disorder.
Each antidepressant differs in its side
effects and in its effectiveness in treating an individual person, but
the majority of people with depression can be treated effectively by one
of these antidepressants.
Side effects of antidepressant
medications.
Antidepressants may cause mild, and
often temporary, side effects (sometimes referred to as adverse effects)
in some people. Typically, these are not serious. However, any reactions
or side effects that are unusual, annoying, or that interfere with
functioning should be reported to the doctor immediately. The most
common side effects of tricyclic antidepressants, and ways to deal with
them, are as follows:
- Dry mouth--it is helpful to
drink sips of water; chew sugarless gum; brush teeth daily.
- Constipation--bran cereals,
prunes, fruit, and vegetables should be in the diet.
- Bladder problems--emptying
the bladder completely may be difficult, and the urine stream may not
be as strong as usual. Older men with enlarged prostate conditions may
be at particular risk for this problem. The doctor should be notified
if there is any pain.
- Sexual problems--sexual
functioning may be impaired; if this is worrisome, it should be
discussed with the doctor.
- Blurred vision--this is
usually temporary and will not necessitate new glasses. Glaucoma
patients should report any change in vision to the doctor.
- Dizziness--rising from the
bed or chair slowly is helpful.
- Drowsiness as a daytime problem--this
usually passes soon. A person who feels drowsy or sedated should not
drive or operate heavy equipment. The more sedating antidepressants
are generally taken at bedtime to help sleep and to minimize daytime
drowsiness.
- Increased heart rate--pulse
rate is often elevated. Older patients should have an
electrocardiogram (EKG) before beginning tricyclic treatment.
The newer antidepressants, including
SSRIs, have different types of side effects, as follows:
- Sexual problems--fairly
common, but reversible, in both men and women. The doctor should be
consulted if the problem is persistent or worrisome.
- Headache--this will usually
go away after a short time.
- Nausea--may occur after a
dose, but it will disappear quickly.
- Nervousness and insomnia (trouble
falling asleep or waking often during the night)--these may occur
during the first few weeks; dosage reductions or time will usually
resolve them.
- Agitation (feeling jittery)--if
this happens for the first time after the drug is taken and is more
than temporary, the doctor should be notified.
- Any of these side effects may be
amplified when an SSRI is combined with other medications that affect
serotonin. In the most extreme cases, such a combination of
medications (e.g., an SSRI and an MAOI) may result in a potentially
serious or even fatal "serotonin syndrome," characterized by fever,
confusion, muscle rigidity, and cardiac, liver, or kidney problems.
The small number of people for whom
MAOIs are the best treatment need to avoid taking decongestants and
consuming certain foods that contain high levels of tyramine, such as
many cheeses, wines, and pickles. The interaction of tyramine with MAOIs
can bring on a sharp increase in blood pressure that can lead to a
stroke. The doctor should furnish a complete list of prohibited foods
that the individual should carry at all times. Other forms of
antidepressants require no food restrictions. MAOIs also should not be
combined with other antidepressants, especially SSRIs, due to the risk
of serotonin syndrome.
Medications of any kind--prescribed,
over-the-counter, or herbal supplements--should never be mixed
without consulting the doctor; nor should medications ever be borrowed
from another person. Other health professionals who may prescribe a
drug-such as a dentist or other medical specialist-should be told that
the person is taking a specific antidepressant and the dosage. Some
drugs, although safe when taken alone, can cause severe and dangerous
side effects if taken with other drugs. Alcohol (wine, beer, and hard
liquor) or street drugs, may reduce the effectiveness of antidepressants
and their use should be minimized or, preferably, avoided by anyone
taking antidepressants. Some people who have not had a problem with
alcohol use may be permitted by their doctor to use a modest amount of
alcohol while taking one of the newer antidepressants. The potency of
alcohol may be increased by medications since both are metabolized by
the liver; one drink may feel like two.
Although not common, some people
have experienced withdrawal symptoms when stopping an antidepressant too
abruptly. Therefore, when discontinuing an antidepressant, gradual
withdrawal is generally advisable.
Questions about any antidepressant
prescribed, or problems that may be related to the medication, should be
discussed with the doctor and/or the pharmacist.
Everyone experiences anxiety at one
time or another--"butterflies in the stomach" before giving a speech or
sweaty palms during a job interview are common symptoms. Other symptoms
include irritability, uneasiness, jumpiness, feelings of apprehension,
rapid or irregular heartbeat, stomachache, nausea, faintness, and
breathing problems.
Anxiety is often manageable and mild,
but sometimes it can present serious problems. A high level or prolonged
state of anxiety can make the activities of daily life difficult or
impossible. People may have generalized anxiety disorder (GAD) or more
specific anxiety disorders such as panic, phobias, obsessive-compulsive
disorder (OCD), or post-traumatic stress disorder (PTSD).
Both antidepressants and antianxiety
medications are used to treat anxiety disorders. The broad-spectrum
activity of most antidepressants provides effectiveness in anxiety
disorders as well as depression. The first medication specifically
approved for use in the treatment of OCD was the tricyclic
antidepressant clomipramine (Anafranil). The SSRIs, fluoxetine (Prozac),
fluvoxamine (Luvox), paroxetine (Paxil), and sertraline (Zoloft)
have now been approved for use with OCD. Paroxetine has also been
approved for social anxiety disorder (social phobia), GAD, and panic
disorder; and sertraline is approved for panic disorder and PTSD.
Venlafaxine (Effexor) has been approved for GAD.
Antianxiety medications include the
benzodiazepines, which can relieve symptoms within a short time. They
have relatively few side effects: drowsiness and loss of coordination
are most common; fatigue and mental slowing or confusion can also occur.
These effects make it dangerous for people taking benzodiazepines to
drive or operate some machinery. Other side effects are rare.
Benzodiazepines vary in duration of
action in different people; they may be taken two or three times a day,
sometimes only once a day, or just on an "as-needed" basis. Dosage is
generally started at a low level and gradually raised until symptoms are
diminished or removed. The dosage will vary a great deal depending on
the symptoms and the individual's body chemistry.
It is wise to abstain from alcohol when
taking benzodiazepines, because the interaction between benzodiazepines
and alcohol can lead to serious and possibly life-threatening
complications. It is also important to tell the doctor about other
medications being taken.
People taking benzodiazepines for weeks
or months may develop tolerance for and dependence on these drugs. Abuse
and withdrawal reactions are also possible. For these reasons, the
medications are generally prescribed for brief periods of time--days or
weeks--and sometimes just for stressful situations or anxiety attacks.
However, some patients may need long-term treatment.
It is essential to talk with the doctor
before discontinuing a benzodiazepine. A withdrawal reaction may occur
if the treatment is stopped abruptly. Symptoms may include anxiety,
shakiness, headache, dizziness, sleeplessness, loss of appetite, or in
extreme cases, seizures. A withdrawal reaction may be mistaken for a
return of the anxiety because many of the symptoms are similar. After a
person has taken benzodiazepines for an extended period, the dosage is
gradually reduced before it is stopped completely. Commonly used
benzodiazepines include clonazepam (Klonopin), alprazolam (Xanax),
diazepam (Valium), and lorazepam (Ativan).
The only medication specifically for
anxiety disorders other than the benzodiazepines is buspirone (BuSpar).
Unlike the benzodiazepines, buspirone must be taken consistently for at
least 2 weeks to achieve an antianxiety effect and therefore cannot be
used on an "as-needed" basis.
Beta blockers, medications often used
to treat heart conditions and high blood pressure, are sometimes used to
control "performance anxiety" when the individual must face a specific
stressful situation--a speech, a presentation in class, or an important
meeting. Propranolol (Inderal, Inderide) is a commonly used beta
blocker.
Children, the elderly, and pregnant and
nursing women have special concerns and needs when taking
psychotherapeutic medications. Some effects of medications on the
growing body, the aging body, and the childbearing body are known, but
much remains to be learned. Research in these areas is ongoing.
In general, the information throughout
this booklet applies to these groups, but the following are a few
special points to keep in mind.
The 1999 MECA Study (Methodology for
Epidemiology of Mental Disorders in Children and Adolescents) estimated
that almost 21 percent of U.S. children ages 9 to 17 had a diagnosable
mental or addictive disorder that caused at least some impairment. When
diagnostic criteria were limited to significant functional
impairment, the estimate dropped to 11 percent, for a total of 4 million
children who suffer from a psychiatric disorder that limits their
ability to function.6
It is easy to overlook the seriousness
of childhood mental disorders. In children, these disorders may present
symptoms that are different from or less clear-cut than the same
disorders in adults. Younger children, especially, and sometimes older
children as well, may not talk about what is bothering them. For this
reason, it is important to have a doctor, another mental health
professional, or a psychiatric team examine the child.
Many treatments are available to help
these children. The treatments include both medications and
psychotherapy--behavioral therapy, treatment of impaired social skills,
parental and family therapy, and group therapy. The therapy used is
based on the child's diagnosis and individual needs.
When the decision is reached that a
child should take medication, active monitoring by all caretakers
(parents, teachers, and others who have charge of the child) is
essential. Children should be watched and questioned for side effects
because many children, especially younger ones, do not volunteer
information. They should also be monitored to see that they are actually
taking the medication and taking the proper dosage on the correct
schedule.
Childhood-onset depression and anxiety
are increasingly recognized and treated. However, the best-known and
most-treated childhood-onset mental disorder is attention deficit
hyperactivity disorder (ADHD). Children with ADHD exhibit symptoms such
as short attention span, excessive motor activity, and impulsivity which
interfere with their ability to function especially at school. The
medications most commonly prescribed for ADHD are called stimulants.
These include methylphenidate (Ritalin, Metadate, Concerta),
amphetamine (Adderall), dextroamphetamine (Dexedrine,
Dextrostat), and pemoline (Cylert). Because of its potential
for serious side effects on the liver, pemoline is not ordinarily used
as a first-line therapy for ADHD. Some antidepressants such as bupropion
(Wellbutrin) are often used as alternative medications for ADHD
for children who do not respond to or tolerate stimulants.
Based on clinical experience and
medication knowledge, a physician may prescribe to young children a
medication that has been approved by the FDA for use in adults or older
children. This use of the medication is called "off-label." Most
medications prescribed for childhood mental disorders, including many of
the newer medications that are proving helpful, are prescribed off-label
because only a few of them have been systematically studied for safety
and efficacy in children. Medications that have not undergone such
testing are dispensed with the statement that "safety and efficacy have
not been established in pediatric patients." The FDA has been urging
that products be appropriately studied in children and has offered
incentives to drug manufacturers to carry out such testing. The National
Institutes of Health and the FDA are examining the issue of medication
research in children and are developing new research approaches.
The use of the other medications
described in this booklet is more limited with children than with
adults. Therefore, a special list of medications for children, with the
ages approved for their use, appears immediately after the general list
of medications. Also listed are NIMH publications with more information
on the treatment of both children and adults with mental disorders.
Persons over the age of 65 make up
almost 13 percent of the population of the United States, but they
receive 30 percent of prescriptions filled. The elderly generally have
more medical problems, and many of them are taking medications for more
than one of these conditions. In addition, they tend to be more
sensitive to medications. Even healthy older people eliminate some
medications from the body more slowly than younger persons and therefore
require a lower or less frequent dosage to maintain an effective level
of medication.
The elderly are also more likely to
take too much of a medication accidentally because they forget that they
have taken a dose and take another one. The use of a 7-day pill-box, as
described earlier in this brochure, can be especially helpful for an
elderly person.
The elderly and those close to
them--friends, relatives, caretakers--need to pay special attention and
watch for adverse (negative) physical and psychological responses to
medication. Because they often take more medications--not only those
prescribed but also over-the-counter preparations and home, folk, or
herbal remedies--the possibility of adverse drug interactions is high.
Because there is a risk of birth
defects with some psychotropic medications during early pregnancy, a
woman who is taking such medication and wishes to become pregnant should
discuss her plans with her doctor. In general, it is desirable to
minimize or avoid the use of medication during early pregnancy. If a
woman on medication discovers that she is pregnant, she should contact
her doctor immediately. She and the doctor can decide how best to handle
her therapy during and following the pregnancy. Some precautions that
should be taken are:7
- If possible, lithium should be
discontinued during the first trimester (first 3 months of pregnancy)
because of an increased risk of birth defects.
- If the patient has been taking an
anticonvulsant such as carbamazepine (Tegretol) or valproic
acid (Depakote)--both of which have a somewhat higher risk than
lithium--an alternate treatment should be used if at all possible. The
risks of two other anticonvulsants, lamotrigine (Lamictal) and
gabapentin (Neurontin) are unknown. An alternative medication
for any of the anticonvulsants might be a conventional antipsychotic
or an antidepressant, usually an SSRI. If essential to the patient's
health, an anticonvulsant should be given at the lowest dose possible.
It is especially important when taking an anticonvulsant to take a
recommended dosage of folic acid during the first trimester.
- Benzodiazepines are not recommended
during the first trimester.
The decision to use a psychotropic
medication should be made only after a careful discussion between the
woman, her partner, and her doctor about the risks and benefits to her
and the baby. If, after discussion, they agree it best to continue
medication, the lowest effective dosage should be used, or the
medication can be changed. For a woman with an anxiety disorder, a
change from a benzodiazepine to an antidepressant might be considered.
Cognitive-behavioral therapy may be beneficial in helping an anxious or
depressed person to lower medication requirements. For women with severe
mood disorders, a course of electroconvulsive therapy (ECT) is sometimes
recommended during pregnancy as a means of minimizing exposure to
riskier treatments.
After the baby is born, there are other
considerations. Women with bipolar disorder are at particularly high
risk for a postpartum episode. If they have stopped medication during
pregnancy, they may want to resume their medication just prior to
delivery or shortly thereafter. They will also need to be especially
careful to maintain their normal sleep-wake cycle. Women who have
histories of depression should be checked for recurrent depression or
postpartum depression during the months after the birth of a child.
Women who are planning to breastfeed
should be aware that small amounts of medication pass into the breast
milk. In some cases, steps can be taken to reduce the exposure of the
nursing infant to the mother's medication, for instance, by timing doses
to post-feeding sleep periods. The potential benefits and risks of
breastfeeding by a woman taking psychotropic medication should be
discussed and carefully weighed by the patient and her physician.
A woman who is taking birth control
pills should be sure that her doctor knows this. The estrogen in these
pills may affect the breakdown of medications by the body--for example,
increasing side effects of some antianxiety medications or reducing
their ability to relieve symptoms of anxiety. Also, some medications,
including carbamazepine and some antibiotics, and an herbal supplement,
St. John's wort, can cause an oral contraceptive to be ineffective.
To find the section of the text that
describes a particular medication in the lists below, find the
generic (chemical) name and look it up on the
first list or find the trade (brand) name and
look it up on the second list. If the name of the medication does not
appear on the prescription label, ask the doctor or pharmacist for it.
(Note: Some drugs are marketed under numerous trade names, not all of
which can be listed in a short publication like this one. If your
medication's trade name does not appear in the list--and some older
medicines are no longer listed by trade names--look it up by its generic
name or ask your doctor or pharmacist for more information.) Stimulant
medications that are used by both children and adults with ADHD are
listed in the children's medications chart).
| GENERIC NAME |
TRADE NAME |
| |
|
Antipsychotic Medications |
| aripiprazole |
Abilify |
| chlorpromazine |
Thorazine |
|
chlorprothixene |
Taractan |
| clozapine |
Clozaril |
| fluphenazine |
Permitil,
Prolixin |
| haloperidol |
Haldol |
| loxapine |
Loxitane |
| mesoridazine |
Serentil |
| molindone |
Lidone, Moban |
| olanzapine |
Zyprexa |
| perphenazine |
Trilafon |
| pimozide (for
Tourette's syndrome) |
Orap |
| quetiapine |
Seroquel |
| risperidone |
Risperdal |
| thioridazine |
Mellaril |
| thiothixene |
Navane |
|
trifluoperazine |
Stelazine |
|
trifluopromazine |
Vesprin |
| ziprasidone |
Geodon |
| |
|
Antimanic Medications |
| carbamazepine |
Tegretol |
| divalproex
sodium (valproic acid) |
Depakote |
| gabapentin |
Neurontin |
| lamotrigine |
Lamictal |
| lithium
carbonate |
Eskalith,
Lithane, Lithobid |
| lithium
citrate |
Cibalith-S |
| topimarate
|
Topamax |
| |
|
Antidepressant Medications |
| amitriptyline |
Elavil |
| amoxapine |
Asendin |
| bupropion |
Wellbutrin |
| citalopram (SSRI) |
Celexa |
| clomipramine |
Anafranil |
| desipramine |
Norpramin,
Pertofrane |
| doxepin |
Adapin,
Sinequan |
| escitalopram (SSRI) |
Lexapro |
| fluvoxamine (SSRI) |
Luvox |
| fluoxetine (SSRI) |
Prozac |
| imipramine |
Tofranil |
| isocarboxazid
(MAOI) |
Marplan |
| maprotiline |
Ludiomil |
| mirtazapine |
Remeron |
| nefazodone |
Serzone |
| nortriptyline |
Aventyl,
Pamelor |
| paroxetine (SSRI) |
Paxil |
| phenelzine (MAOI) |
Nardil |
| protriptyline |
Vivactil |
| sertraline (SSRI) |
Zoloft |
|
tranylcypromine (MAOI) |
Parnate |
| trazodone |
Desyrel |
| trimipramine |
Surmontil |
| venlafaxine |
Effexor |
| |
|
Antianxiety Medications |
| (All of
these antianxiety medications except buspirone are benzodiazepines) |
| alprazolam |
Xanax |
| buspirone |
BuSpar |
|
chlordiazepoxide |
Librax,
Libritabs, Librium |
| clonazepam |
Klonopin |
| clorazepate |
Azene,
Tranxene |
| diazepam |
Valium |
| halazepam |
Paxipam |
| lorazepam |
Ativan |
| oxazepam |
Serax |
| prazepam |
Centrax |
| TRADE NAME |
GENERIC NAME |
| |
|
Antipsychotic Medications |
| Abilify |
aripiprazole |
| Clozaril |
clozapine |
| Geodon |
ziprasidone |
| Haldol |
haloperidol |
| Lidone |
molindone |
| Loxitane |
loxapine |
| Mellaril |
thioridazine |
| Moban |
molindone |
| Navane |
thiothixene |
| Orap (for
Tourette's syndrome) |
pimozide |
| Permitil |
fluphenazine |
| Prolixin |
fluphenazine |
| Risperdal |
risperidone |
| Serentil |
mesoridazine |
| Seroquel |
quetiapine |
| Stelazine |
trifluoperazine |
| Taractan |
chlorprothixene |
| Thorazine |
chlorpromazine |
| Trilafon |
perphenazine |
| Vesprin |
trifluopromazine |
| Zyprexa |
olanzapine |
| |
|
Antimanic Medications |
| Cibalith-S |
lithium
citrate |
| Depakote |
valproic acid,
divalproex sodium |
| Eskalith |
lithium
carbonate |
| Lamictal |
lamotrigine |
| Lithane |
lithium
carbonate |
| Lithobid |
lithium
carbonate |
| Neurontin |
gabapentin |
| Tegretol |
carbamazepine |
| Topamax |
topiramate |
| |
|
Antidepressant Medications |
| Adapin |
doxepin |
| Anafranil |
clomipramine |
| Asendin |
amoxapine |
| Aventyl |
nortriptyline |
| Celexa (SSRI) |
citalopram |
| Desyrel |
trazodone |
| Effexor |
venlafaxine |
| Elavil |
amitriptyline |
| Lexapro (SSRI) |
escitalopram |
| Ludiomil |
maprotiline |
| Luvox (SSRI) |
fluvoxamine |
| Marplan (MAOI) |
isocarboxazid |
| Nardil (MAOI) |
phenelzine |
| Norpramin |
desipramine |
| Pamelor |
nortriptyline |
| Parnate (MAOI) |
tranylcypromine |
| Paxil (SSRI) |
paroxetine |
| Pertofrane |
desipramine |
| Prozac (SSRI) |
fluoxetine |
| Remeron |
mirtazapine |
| Serzone |
nefazodone |
| Sinequan |
doxepin |
| Surmontil |
trimipramine |
| Tofranil |
imipramine |
| Vivactil |
protriptyline |
| Wellbutrin |
bupropion |
| Zoloft (SSRI) |
sertraline |
| |
|
Antianxiety Medications |
| (All of
these antianxiety medications except BuSpar are benzodiazepines) |
| Ativan |
lorazepam |
| Azene |
clorazepate |
| BuSpar |
buspirone |
| Centrax |
prazepam |
| Librax,
Libritabs, Librium |
chlordiazepoxide |
| Klonopin |
clonazepam |
| Paxipam |
halazepam |
| Serax |
oxazepam |
| Tranxene |
clorazepate |
| Valium |
diazepam |
| Xanax |
alprazolam |
| TRADE NAME |
GENERIC NAME |
APPROVED AGE |
| |
|
Stimulant Medications |
| Adderall |
amphetamine |
3 and older |
| Adderall XR |
amphetamine
(extended release) |
6 and older |
| Concerta |
methylphenidate
(long acting) |
6 and older |
| Cylert* |
pemoline |
6 and older |
| Dexedrine |
dextroamphetamine |
3 and older |
| Dextrostat |
dextroamphetamine |
3 and older |
| Focalin |
dexmethylphenidate |
6 and older |
| Metadate ER |
methylphenidate
(extended release) |
6 and older |
| Ritalin |
methylphenidate |
6 and older |
|
Non-stimulant for ADHD |
| Strattera |
atomoxetine |
6 and older |
|
*Because
of its potential for serious side effects affecting the liver,
Cylert should not ordinarily be considered as first-line drug
therapy for ADHD. |
| |
|
Antidepressant and Antianxiety Medications |
| Anafranil |
clomipramine |
10 and older
(for OCD) |
| BuSpar |
buspirone |
18 and older |
| Effexor |
venlafaxine |
18 and older |
| Luvox (SSRI) |
fluvoxamine |
8 and older
(for OCD) |
| Paxil (SSRI) |
paroxetine |
18 and older |
| Prozac (SSRI) |
fluoxetine |
18 and older |
| Serzone (SSRI) |
nefazodone |
18 and older |
| Sinequan |
doxepin |
12 and older |
| Tofranil |
imipramine |
6 and older
(for bedwetting) |
| Wellbutrin |
bupropion |
18 and older |
| Zoloft (SSRI) |
sertraline |
6 and older
(for OCD) |
| |
|
Antipsychotic Medications |
| Clozaril
(atypical) |
clozapine |
18 and older |
| Haldol |
haloperidol |
3 and older |
| Risperdal
(atypical) |
risperidone |
18 and older |
| Seroquel
(atypical) |
quetiapine |
18 and older |
| Mellaril |
thioridazine |
2 and older |
| Zyprexa
(atypical) |
olanzapine |
18 and older |
| Orap |
pimozide |
12 and older
(for Tourette's syndrome -- Data for age 2 and older indicate
similar safety profile) |
| |
| Mood
Stabilizing Medications |
| Cibalith-S
|
lithium
citrate |
12 and older |
| Depakote |
valproic acid |
2 and older
(for seizures) |
| Eskalith |
lithium
carbonate |
12 and older |
| Lithobid |
lithium
carbonate |
12 and older |
| Tegretol |
carbamazepine |
any age (for
seizures) |
1Fenton WS. Prevalence of
spontaneous dyskinesia in schizophrenia. Journal of Clinical
Psychiatry, 2000; 62 (suppl 4): 10-14.
2Bowden CL, Calabrese JR,
McElroy SL, Gyulai L, Wassef A, Petty F, et al. For the Divalproex
Maintenance Study Group. A randomized, placebo-controlled 12-month trial
of divalproex and lithium in treatment of outpatients with bipolar I
disorder. Archives of General Psychiatry, 2000; 57(5): 481-489.
3Vainionpää LK, Rättyä J,
Knip M, Tapanainen JS, Pakarinen AJ, Lanning P, et al. Valproate-induced
hyperandrogenism during pubertal maturation in girls with epilepsy.
Annals of Neurology, 1999; 45(4): 444-450.
4Soames JC. Valproate
treatment and the risk of hyperandrogenism and polycystic ovaries.
Bipolar Disorder, 2000; 2(1): 37-41.
5Thase ME, and Sachs GS.
Bipolar depression: Pharmacotherapy and related therapeutic strategies.
Biological Psychiatry, 2000; 48(6): 558-572.
6Department of Health and
Human Services. 1999. Mental Health: A Report of the Surgeon General.
Rockville, MD: Department of Health and Human Services, Substance Abuse
and Mental Health Services Administration, Center for Mental Health
Services, National Institute of Mental Health.
7Altshuler LL, Cohen L,
Szuba MP, Burt VK, Gitlin M, and Mintz J. Pharmacologic management of
psychiatric illness during pregnancy: Dilemmas and guidelines.
American Journal of Psychiatry, 1996; 153(5): 592-606.
8Physicians'
Desk Reference, 54th edition. Montavale, NJ:
Medical Economics Data Production Co. 2000.
This is the 4th edition of
Medications. It was revised by Margaret Strock, staff member in the
Information Resources and Inquiries Branch, Office of Communications and
Public Liaison, National Institute of Mental Health (NIMH). Scientific
review was provided by Wayne Fenton, M.D., Henry Haigler, M.D., Ellen
Leibenluft, M.D., Matthew Rudorfer, M.D., and Benedetto Vitiello, M.D.
Editorial assistance was provided by Lisa Alberts and Ruth Dubois.
All material in this brochure is in
the public domain and may be reproduced or copied without permission
from the Institute. Citation of the National Institute of Mental Health
as the source is appreciated.
NIH Publication No. 02-3929
Revised April 2002 |